千金药业：上半年净利润1.28亿元，同比增长8.5%

Group 1 - The company, Qianjin Pharmaceutical, reported a revenue of 1.818 billion yuan for the first half of 2025, representing a year-on-year decrease of 5.52% [1] - The net profit attributable to shareholders of the listed company was 128 million yuan, showing a year-on-year increase of 8.5% [1] - The basic earnings per share were 0.3012 yuan [1]